Trial intelligence / Profile preview

Gam-COVID-Vac Lyo in healthy volunteers

NCT04437875Phase 2Completed

Start
Jun 2020
Primary completion
Aug 2020
Modality
Viral Vector Vaccines
Countries
1
01

Overview

A Phase 2 trial of Gam-COVID-Vac Lyo in coronavirus disease 2019 (COVID-19). Started Jun 2020; status: completed.

02

Drugs

Gam-COVID-Vac Lyo
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04437875.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04437875.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call